These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9112346)

  • 1. Islet rejection in perforin-deficient mice: the role of perforin and Fas.
    Ahmed KR; Guo TB; Gaal KK
    Transplantation; 1997 Apr; 63(7):951-7. PubMed ID: 9112346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles.
    Sleater M; Diamond AS; Gill RG
    Am J Transplant; 2007 Aug; 7(8):1927-33. PubMed ID: 17617855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing.
    Zhan Y; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2001 Dec; 167(11):6279-85. PubMed ID: 11714791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of T cell-mediated endothelial apoptosis.
    Krupnick AS; Kreisel D; Popma SH; Balsara KR; Szeto WY; Krasinskas AM; Riha M; Wells AD; Turka LA; Rosengard BR
    Transplantation; 2002 Sep; 74(6):871-6. PubMed ID: 12364869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas ligand-mediated bystander lysis of syngeneic cells in response to an allogeneic stimulus.
    Smyth MJ
    J Immunol; 1997 Jun; 158(12):5765-72. PubMed ID: 9190927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
    Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
    J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of effector mechanisms in murine cardiac allograft rejection.
    Alexander DZ; Pearson TC; Hendrix R; Ritchie SC; Larsen CP
    Transpl Immunol; 1996 Mar; 4(1):46-8. PubMed ID: 8762009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
    Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
    J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cells are capable of rejecting pancreatic islet xenografts.
    Yi S; Feng X; Hawthorne W; Patel A; Walters S; O'Connell PJ
    Transplantation; 2000 Sep; 70(6):896-906. PubMed ID: 11014643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA; Ward B; Schatzle JD; Bennett M
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis is involved in acute cardiac allograft rejection in rats.
    Kageyama Y; Li XK; Suzuki S; Suzuki H; Suzuki K; Kazui T; Harada Y
    Ann Thorac Surg; 1998 Jun; 65(6):1604-9. PubMed ID: 9647066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo.
    Smyth MJ; Kershaw MH; Trapani JA
    Transplantation; 1997 Apr; 63(8):1171-8. PubMed ID: 9133481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection.
    Selvaggi G; Ricordi C; Podack ER; Inverardi L
    Transplantation; 1996 Dec; 62(12):1912-5. PubMed ID: 8990386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic pathways in the skin allograft rejection by CD4+ T cells.
    Ito A; Minagawa M; Tomiyama K; Ito M; Kawai K
    Transplantation; 1999 Jul; 68(1):97-100. PubMed ID: 10428275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
    Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
    J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.
    Yasukawa M; Ohminami H; Arai J; Kasahara Y; Ishida Y; Fujita S
    Blood; 2000 Apr; 95(7):2352-5. PubMed ID: 10733506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts.
    Diamond AS; Gill RG
    J Immunol; 2000 Jul; 165(1):247-55. PubMed ID: 10861058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Fas ligand to cardiac allograft rejection.
    Seino K; Kayagaki N; Bashuda H; Okumura K; Yagita H
    Int Immunol; 1996 Sep; 8(9):1347-54. PubMed ID: 8921411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.